Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has issued an update.
Piramal Pharma Limited has issued a corporate guarantee for its subsidiaries, Piramal Dutch Holdings N.V. and PPL Pharma Inc., to secure financing arrangements worth USD 216 million. This transaction, conducted on an arm’s length basis, is currently a contingent liability and has no immediate impact on the company’s financial status or stakeholder interests.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. It provides services and solutions to various sectors, including healthcare, research, and therapeutic areas, with a market focus on innovation and global reach.
YTD Price Performance: -6.29%
Average Trading Volume: 532,319
Current Market Cap: 320.7B INR
See more insights into PPLPHARMA stock on TipRanks’ Stock Analysis page.